Company: XXC
Filing Date: 2025-06-10
Form Type: F-1/A
Source: 0001213900-25-052817
Chunk: 237

Company: XINXU COPPER INDUSTRY TECHNOLOGY Ltd
Filing Date: 2025-06-10
Form: F-1/A
Chunk 237
---
000 will be paid to the Representatives upon the receipt of the “No Objection Letter” from FINRA. The underwriters’ out -of-pocketexpenses include, but not limited to: (i) reasonable fees of legal counsel incurred by the underwriters in connection with the offering; (ii) all third party due diligence include the cost of any background checks; (iii) book -buildingand prospectus tracking software; (iv) reasonable roadshow expenses; and (iv) preparation of bound volumes and Lucite cube mementos in such quantities as the underwriters may reasonably request. Any paid but unused advance will be returned to us to the extent such out -of-pocketaccountable expenses are not actually incurred in accordance with FINRA Rule 5110(g)(4)(A). In addition, we have agreed to pay $100,000 to the Representatives for their non -accountableexpenses at the closing of this offering. Underwriter Warrants We have agreed to issue warrants to the Representatives to purchase a number of ordinary shares equal to 6% of the total number of shares sold in this offering at an exercise price equal to 125% of the public offering price of the shares sold in this offering. These warrants will have a cashless exercise provision and will be exercisable at any time and from time to time, in whole or in part during the four -andhalf -yearperiod commencing six months from the commencement of sales of this offering. The underwriters’ warrants and the underlying shares may be deemed to be compensation by FINRA, and therefore will be subject to FINRA Rule 5110(e)(1). In accordance with FINRA Rule 5110(e)(1), neither the underwriters’ warrants nor any of our shares issued upon exercise of the underwriters’ warrants may be sold, transferred, assigned, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities by any person, for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which the underwriters warrants are being issued, subject to certain exceptions. In addition, these warrants will not be exercisable for more than five years from the commencement of sales of this offering pursuant to FINRA Rule 5110(g)(8)(A). These warrants do not contain anti -dilutionterms that allow the Representatives to receive more shares or to exercise at a lower price than originally agreed